Innogest Capital

Innogest Capital is a venture capital firm founded in 2006, with offices in Turin, Milan, Geneva, and San Francisco. The firm manages approximately €200 million in assets, focusing on seed and early-stage investments in technology and life sciences sectors. Innogest Capital partners with local and international research centers and technology transfer offices to support entrepreneurs in industrial and international development.

The firm's investment strategy emphasizes medical devices, diagnostics, and digital health, particularly in therapeutic areas such as oncology, cardiology, and neurology. In the digital sector, Innogest Capital invests in foodtech, fintech, fashion-tech, and lifestyle verticals. Over the past decade, the firm has invested in 26 digital companies, raising over €100 million, and has a history of backing companies in cardiovascular diseases, neurological disorders, and oncology.

Innogest Capital collaborates with a network of industry executives and successful entrepreneurs with hands-on experience in venture building and growth. The firm is well-connected to clinical and industrial networks, partnering with them to boost its portfolio. Innogest Capital maintains a bullish view on life sciences in general and an even more bullish stance on cardiovascular health.